Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000820096-13-000005
Filing Date
2013-05-07
Accepted
2013-05-07 09:17:45
Documents
11
Period of Report
2013-03-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2013q310q.htm 10-Q 1605046
2 AMENDMENT TO THE 2011 CREDIT AGREEMENT a2013q3ex101.htm EX-10.1 108979
3 RULE 13A-14(A) CERTIFICATIONS a2013q3ex31.htm EX-31 12148
4 RULE 13A-14(A) CERTIFICATIONS a2013q3ex311.htm EX-31.1 12155
5 SECTION 1350 CERTIFICATIONS a2013q3ex32.htm EX-32 9096
  Complete submission text file 0000820096-13-000005.txt   11878330

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prgo-20130330.xml EX-101.INS 2170380
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20130330.xsd EX-101.SCH 46740
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prgo-20130330_cal.xml EX-101.CAL 93525
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prgo-20130330_def.xml EX-101.DEF 306978
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20130330_lab.xml EX-101.LAB 662122
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20130330_pre.xml EX-101.PRE 371079
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address 515 EASTERN AVENUE ALLEGAN MI 49010 2696738451
PERRIGO CO (Filer) CIK: 0000820096 (see all company filings)

EIN.: 382799573 | State of Incorp.: MI | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-19725 | Film No.: 13818170
SIC: 2834 Pharmaceutical Preparations